Drug Profile
Tyrosine/melanin - Tyme Technologies
Alternative Names: Next generation SM-88; Tyrosine-bound melanin; Tyrosine/melaninLatest Information Update: 15 Nov 2022
Price :
$50
*
At a glance
- Originator Tyme Technologies
- Class Amino acids; Anti-inflammatories; Antineoplastics; Oxidants
- Mechanism of Action Free radical stimulants; Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Cancer